Lilly Ventures

Lilly Ventures is a single-family office managing capital derived from the Lilly pharmaceutical fortune. It operates independently from Eli Lilly and Company and is not a corporate venture capital arm. The firm does not require portfolio companies to have strategic alignment with Eli Lilly's drug pipeline, and it makes investment decisions based on financial return potential rather than corporate development objectives.

Both entities trace their wealth origin to the same family, but they are operationally separate. The Lilly Endowment, a philanthropic foundation holding a substantial equity stake in Eli Lilly and Company, pursues a diversified endowment-style investment strategy with assets historically reported in the $15B to $20B range. Lilly Ventures is a smaller, independent family-office vehicle focused specifically on venture capital and growth-stage investments in healthcare and technology.

The firm concentrates on early-stage investments, typically from pre-seed through Series B rounds. Its focus is venture capital rather than late-stage growth equity or buyouts. Lilly Ventures seeks companies where a pharmaceutical lens can identify scientific or operational merit that generalist investors may overlook, often entering deals alongside specialist health-tech venture firms.

Yes. The firm maintains investment offices in Moscow, Russia, and Melbourne, Australia, in addition to its US locations in Indianapolis, San Francisco, Boston, and New Brunswick. Its investment mandate is borderless, with a track record of direct venture investments across North America, Eastern Europe, and Australia, particularly in research-intensive innovation clusters.

Lilly Ventures is structured as a single-family office and deploys principal capital from the Lilly family wealth. There is no public record of the firm accepting third-party capital or operating as a multi-family office. Its investment approach — concentrated, early-stage, and independent of the pharmaceutical parent company — aligns with the typical posture of a single-family direct-investment vehicle.